Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Rostami

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Brain & Spine|June 29, 2023
Huge variability in restrictions of mobilization for patients with aneurysmal subarachnoid hemorrhage - A European survey of practiceIftakher Hossain, Alexander Younsi, Ana Maria Castaño Leon, et al.
Frontiers in Neurology|July 28, 2012
A Model for Mild Traumatic Brain Injury that Induces Limited Transient Memory Impairment and Increased Levels of Axon Related Serum BiomarkersElham Rostami, Johan Davidsson, Kian Chye Ng, et al.
Plos One|August 26, 2022
Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironmentsElham Rostami, Mohsen Bakhshandeh, Haniyeh Ghaffari-Nazari, et al.
European Journal of Neurology|December 28, 2020
Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severityJohan Virhammar, Anja Nääs, David Fällmar, et al.
Nature Communications|October 16, 2024
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19August F Jernbom, Lovisa Skoglund, Elisa Pin, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|November 20, 2021
The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive careDavid Fällmar, Elham Rostami, Eva Kumlien, et al.
The Journal of Infectious Diseases|March 21, 2021
Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological SymptomsJanet L Cunningham, Johan Virhammar, Bengt Rönnberg, et al.
Brain, Behavior, and Immunity|November 30, 2024
Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responsesXueqi Li, Arvid Edén, Susmita Malwade, et al.
Neurology|June 27, 2020
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluidJohan Virhammar, Eva Kumlien, David Fällmar, et al.
Clinical Genetics|February 3, 2024
Contribution of genetic variants in the development of familial premature coronary artery disease in a cohort of cardiac patientsSepideh Mehvari, Nahid Karimian Fathi, Sara Saki, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Brain & Spine|June 29, 2023
Huge variability in restrictions of mobilization for patients with aneurysmal subarachnoid hemorrhage - A European survey of practiceIftakher Hossain, Alexander Younsi, Ana Maria Castaño Leon, et al.
Frontiers in Neurology|July 28, 2012
A Model for Mild Traumatic Brain Injury that Induces Limited Transient Memory Impairment and Increased Levels of Axon Related Serum BiomarkersElham Rostami, Johan Davidsson, Kian Chye Ng, et al.
Plos One|August 26, 2022
Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironmentsElham Rostami, Mohsen Bakhshandeh, Haniyeh Ghaffari-Nazari, et al.
European Journal of Neurology|December 28, 2020
Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severityJohan Virhammar, Anja Nääs, David Fällmar, et al.
Nature Communications|October 16, 2024
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19August F Jernbom, Lovisa Skoglund, Elisa Pin, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|November 20, 2021
The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive careDavid Fällmar, Elham Rostami, Eva Kumlien, et al.
The Journal of Infectious Diseases|March 21, 2021
Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological SymptomsJanet L Cunningham, Johan Virhammar, Bengt Rönnberg, et al.
Brain, Behavior, and Immunity|November 30, 2024
Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responsesXueqi Li, Arvid Edén, Susmita Malwade, et al.
Neurology|June 27, 2020
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluidJohan Virhammar, Eva Kumlien, David Fällmar, et al.
Clinical Genetics|February 3, 2024
Contribution of genetic variants in the development of familial premature coronary artery disease in a cohort of cardiac patientsSepideh Mehvari, Nahid Karimian Fathi, Sara Saki, et al.
Pageof 10